TGA media releases & statements 2013

The following media releases and statements were issued by the TGA in 2013.

May

  • 19 April 2013
    Mojo Risen Capsules pose a serious risk to your health and should not be taken. The Therapeutic Goods Administration (TGA) has tested Mojo …
  • 18 April 2013
    Ziyinzhuangyang tablets pose a serious risk to your health and should not be taken. The Therapeutic Goods Administration (TGA) has tested …
  • 18 April 2013
    Maxman III capsules pose a serious risk to your health and should not be taken. The Therapeutic Goods Administration (TGA) has tested …
  • 18 April 2013
    A new streamlined process for assessing medicines sold over the counter takes effect week starting 15 April 2013, marking a major step …
  • 17 April 2013
    Health professionals and consumers are advised that Abbott Diabetes Care, after consultation with the TGA, has initiated a recall for …
  • 12 April 2013
    The TGA is providing updated information to the public and to health professionals about the regulatory status of dextropropoxyphene- …
  • 10 April 2013
    Later updates Date Link/s 24 September 2014 AcrySof Cachet phakic lens - update Health professionals and consumers are advised that Alcon …
  • 10 April 2013
    Health professionals and consumers are advised that Medtronic, in consultation with the TGA, has issued information regarding three …
  • 4 April 2013
    An article in the Adelaide Advertiser on 2 April 2013 claimed that the TGA National Manager had made certain statements about the quality …
  • 3 April 2013
    Health professionals and consumers are advised that Johnson & Johnson Medical Pty Ltd, after consultation with the TGA, is recalling …
  • 3 April 2013
    Health professionals and consumers are advised that Hoya Surgical Optics, in consultation with the TGA, is recalling certain Hoya One-Piece …